Head-to-head · Cost-Efficiency Index
Superior Remedies vs Framework
Two GLP-1 programs on the bench, scored on the same six factors. Here's how their real cost of ownership compares — and which one we'd start with.
Superior Remedies
Readers who want a low-dose protocol designed on its own terms rather than a smaller version of a weight-loss plan, and who do not mind starting an eligibility check to learn the price.
Visit Superior RemediesFramework
Cost-first shoppers who want doctor-guided treatment selection with a named pharmacy, if you can accept learning the price only after intake.
Visit FrameworkThe verdict
Superior Remedies takes it, leading the Cost-Efficiency Index 46 to 45. Superior Remedies runs three named programs — semaglutide, tirzepatide, and a dedicated GLP-1 Microdose protocol for longevity and body composition — and publishes no price for any of them. Framework still earns a C — Cost-first shoppers who want doctor-guided treatment selection with a named pharmacy, if you can accept learning the price only after intake.
Worth knowing either way: our overall #1 pick is CoreAge Rx (Cost-Efficiency Index 94/100 — the top of the ranking). See how it stacks up: CoreAge Rx vs Superior Remedies.
Factor by factor
Both providers scored on our six Cost-Efficiency Index factors. The stronger side on each row is marked in teal.
Normalized Cost/Month
Price Transparency
Nationwide Access
Formulation Options
Clinical Oversight
Contract Flexibility
Pricing, coverage & formulary
The disclosed facts behind the scores. Lower price wins its row (teal).
| Spec | Superior Remedies | Framework |
|---|---|---|
| Cost-Efficiency Index | 46/100 | 45/100 |
| Semaglutide / mo | Not disclosed | Not disclosed |
| Tirzepatide / mo | Not disclosed | Not disclosed |
| Semaglutide / yr (modeled) | — | — |
| Tirzepatide / yr (modeled) | — | — |
| Coverage | 7 states | Coverage not published |
| Oral / sublingual | No | No |
| Brand-name access | Compounded only | Compounded only |
| Rank here | #462 | #463 |
Superior Remedies
46/100Where the value is
- Runs a dedicated GLP-1 Microdose program with its own page, framed for metabolic health and body composition rather than aggressive weight loss
- Publishes a clinical exclusion that turns business away: patients with significant weight to lose are told they would be better served by a standard GLP-1 protocol
- Charges nothing if you are not approved
The tradeoffs
- Serves only seven states (CA, IL, MI, NY, UT, VA, WI) per its own treatment-page FAQ and contact page, not the nationwide footprint the marketing implies
- No price on any program page — the only public figure is a homepage headline labeled a limited-time offer and attached to the general pitch rather than to a program
Framework
45/100Where the value is
- The compounding pharmacy partner is named, which most of this field does not do
- Treatment selection is doctor-guided rather than a fixed product menu
- US-licensed clinicians and a 503A pharmacy pathway
The tradeoffs
- No monthly medication price is published: the tirzepatide and semaglutide pages carry no price at all, and the homepage advertises a per-week figure for 'GLP-1s' generally rather than a rate for either drug
- The only drug-specific prices anywhere on the site sit on a legacy page — semaglutide at $349 per three months and tirzepatide at $549 per three months
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. Pricing, states and verification reflect each provider's public disclosures at last review; prices change — confirm on the provider's site. Not medical advice. See our disclosure.